Cargando…
High Expression of Glycolytic Genes in Clinical Glioblastoma Patients Correlates With Lower Survival
Glioblastoma (GBM), the most aggressive brain tumor, is associated with a median survival at diagnosis of 16–20 months and limited treatment options. The key hallmark of GBM is altered tumor metabolism and marked increase in the rate of glycolysis. Aerobic glycolysis along with elevated glucose cons...
Autores principales: | Stanke, Kimberly M, Wilson, Carrick, Kidambi, Srivatsan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8740031/ https://www.ncbi.nlm.nih.gov/pubmed/35004842 http://dx.doi.org/10.3389/fmolb.2021.752404 |
Ejemplares similares
-
Moonlight functions of glycolytic enzymes in cancer
por: Shegay, Petr V., et al.
Publicado: (2023) -
Elevated expression of glycolytic genes as a prominent feature of early-onset preeclampsia: insights from integrative transcriptomic analysis
por: He, Jie, et al.
Publicado: (2023) -
Identification of Alternative Allosteric Sites in Glycolytic Enzymes for Potential Use as Species-Specific Drug Targets
por: Ayyildiz, Merve, et al.
Publicado: (2020) -
Multi-omic analysis of glycolytic signatures: exploring the predictive significance of heterogeneity and stemness in immunotherapy response and outcomes in hepatocellular carcinoma
por: Zhang, Shiyu, et al.
Publicado: (2023) -
Immune-Inhibitory Gene Expression is Positively Correlated with Overall Immune Activity and Predicts Increased Survival Probability of Cervical and Head and Neck Cancer Patients
por: Budhwani, Megha, et al.
Publicado: (2021)